Design, Development and Evaluation of Tetracycline Controlled Release Microspheres
DOI:
https://doi.org/10.22270/ajprd.v11i6.1326Keywords:
Microspheres, Cross-linking agent, Controlled release, Encapsulation.Abstract
Microsphere drug delivery methods have been used to boost efficacy, reduce toxicity, and improve patient compliance. Additional benefits of using microspheres to deliver medications include controlled drug release, improved bioavailability, and targeted drug delivery to the desired location. In order to achieve the required therapeutic effect, hydroxypropyl methyl cellulose K4M and sodium alginate are used as a polymer in microsphere delivery system and different concentration of aluminium chloride is used as cross linking agent. The advantage of microsphere formulations over traditional tablet or capsule formulations is that they increase the surface area exposed to the absorption site, boosting medication absorption and reducing drug dose frequency. Tetracycline is a broad-spectrum antibiotic that is frequently used to treat illnesses like pneumonia and respiratory tract infections. The encapsulation effectiveness, particle size, in -vitro release analysis and release kinetics of the microsphere formulations was assessed.
Downloads
References
2. Midha K, Nagpal M, Arora S. Microspheres: a recent update. Int. J. Recent. Sci. Res. 2015 Jul; 50(8):5859-67.
3. Alex R, Bodmeier R. Encapsulation of water-soluble drugs by a modified solvent evaporation method. I. Effect of process and formulation variables on drug entrapment. Journal of microencapsulation. 1990 Jan 1; 7(3):347-55.
4. Anal AK. Time-controlled pulsatile delivery systems for bioactive compounds. Recent Patents on Drug Delivery & Formulation. 2007 Feb 1; 1(1):73-9.
5. Thaker M, Spanogiannopoulos P, Wright GD. The tetracycline resistome. Cellular and Molecular Life Sciences. 2010 Feb; 67(3):419-31.
6. Wheatley MA, Chang M, Park E, Langer R. Coated alginate microspheres: factors influencing the controlled delivery of macromolecules. Journal of Applied Polymer Science. 1991 Dec 5; 43(11):2123-35.
7. Champion JA, Walker A, Mitragotri S. Role of particle size in phagocytosis of polymeric microspheres. Pharmaceutical research. 2008 Aug; 25(8):1815-21.
8. González-Rodrıguez ML, Holgado MA, Sanchez-Lafuente C, Rabasco AM, Fini A. Alginate/chitosan particulate systems for sodium diclofenac release. International Journal of Pharmaceutics. 2002 Jan 3; 232(1-2):225-34.
9. D’Souza S. A review of in vitro drug release test methods for nano-sized dosage forms. Advances in Pharmaceutics. 2014 Nov 20.
10. Sakore, S., Chakraborty, B. Formulation and evaluation of enalapril maleate controlled release matrix. Int J Pharm Biomed Res, 2014; 4(1):21 –26.
Published
How to Cite
Issue
Section
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.